PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies (Q42623661)

From Wikidata
Jump to navigation Jump to search
scientific article published on 3 November 2011
edit
Language Label Description Also known as
English
PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies
scientific article published on 3 November 2011

    Statements

    PRDM16 (1p36) translocations define a distinct entity of myeloid malignancies with poor prognosis but may also occur in lymphoid malignancies (English)
    Francois P Duhoux
    Carmen P Montano-Almendras
    Marie J Mozziconacci
    Pascaline Talmant
    Steven Richebourg
    Christian Herens
    Stéphanie Struski
    Francine Mugneret
    Catherine Roche-Lestienne
    Dominique Latinne
    Jeanne M Libouton
    Hélène A Poirel
    Groupe Francophone de Cytogénétique Hématologique (GFCH)
    Belgian Cytogenetic Group for Haematology and Oncology (BCG-HO)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit